Publication | Closed Access
Escalation to natalizumab or switching among immunomodulators in relapsing multiple sclerosis
93
Citations
30
References
2011
Year
We suggest that an escalation to natalizumab is more effective than switching among immunomodulators in RRMS patients who failed a first-line treatment.
| Year | Citations | |
|---|---|---|
Page 1
Page 1